Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls

scientific article

Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID12820312

P2093author name stringRupp J
Hardt PD
Kloer HU
Ngoumou B
Toepler M
P433issue2A
P407language of work or nameEnglishQ1860
P921main subjectfecesQ496
colorectal carcinomaQ25493920
colorectal cancerQ188874
P304page(s)851-853
P577publication date2003-03-01
P1433published inAnticancer ResearchQ326290
P1476titleMeasurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls
P478volume23

Reverse relations

cites work (P2860)
Q39787266A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1
Q35202822Blood-based protein biomarker panel for the detection of colorectal cancer
Q37578725Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled
Q36664505Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase
Q33865884Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.
Q33503436Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasia
Q28071714Epigenetics in diagnosis of colorectal cancer
Q24616985Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis
Q24645339Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
Q42846847Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening
Q41669982PKM2, a Central Point of Regulation in Cancer Metabolism
Q54962725Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
Q33761481Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang
Q33275224Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma
Q38245395Rectal effluent as a research tool
Q28542871Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression
Q35687171The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer
Q33208410The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus
Q37337541The value of expression of M2-PK and VEGF in patients with advanced gastric cancer
Q28263391Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls

Search more.